Chemical and Pharmaceutical Bulletin p. 2564 - 2573 (1991)
Update date:2022-08-05
Topics:
Kurokawa
Sato
Masuda
Yoshida
Ochi
Zushi
Fujiwara
Naruto
Uno
Matsumoto
A series of 11-[4-(cinnamyl)-1-piperazinyl]-6,11-dihydrodibenz[b,e]oxepins and related compounds were synthesized and evaluated for their protective activities against complete ischemia, normobaric hypoxia, lipidperoxidation and convulsion. Structure-activity relationship studies of this series led to the finding of (E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-prop enyl)piperazine dimaleate (50), AJ-3941 with the most appropriate property for combined pharmacological activities. Compound 50 also shows an inhibitory effect against cerebral edema as well when orally given to rats.
View MoreHangzhou Donglou Bio-nutrient Co., Ltd.
Contact:+86-571-82225795,13967112289
Address:Louta Town, Xiaoshan,Hangzhou,Zhejiang
Huangshi Meifeng Chemical Co.,ltd.
Contact:+86-714-6516706
Address:1941-4-3#,Hubin Avenue,Huangshi,Hubei,China
Fiarpharmatech Co., Ltd.(expird)
Contact:13482436141
Address:Room 1138, Building 3, No. 555, Huancheng Road(West), Fenxian District, Shanghai
AUSHUN PHARMACEUTICAL TECHNOLOGY CO,.LTD
Contact:+86-25-86883560 15951806178
Address:14 Dayingbi, Zhujiang Rd. East, Nanjing, Jiangsu, China.
Liaoyang Xinyou Chemical Products Co.,Ltd.
Contact:+86-419-5165433 13604191870
Address:Huishang Road6-1, Hongwei District, Liaoyang, Liaoning, China
Doi:10.1016/j.tet.2017.06.034
(2017)Doi:10.1021/jo00406a026
(1978)Doi:10.1055/s-1978-24663
(1978)Doi:10.1016/j.molstruc.2003.09.016
(2004)Doi:10.1002/hlca.19780610128
(1978)Doi:10.1002/jlcr.2580130407
(1977)
